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ABSTRACT 
Intrahepatic cholestasis of pregnancy (idiopathic jaundice of pregnancy, 
recurrent familial jaundice of pregnancy) is a benign familial disease 
manifesting itself in the gestational period in itching and (or) jaundice. As 
a rule, the disease is observed in the 3rd trimester of pregnancy, that is in 
the 28th-30th week, and may disappear by itself a few days after labor and 
recur during future pregnancies. 
The aim of this research is to study the role and factors of vascular 
homeostasis regulation in women with infertility treated with assisted 
reproductive technologies (ART) and with concomitant intrahepatic 
cholestasis. 
KEYWORDS 
pregnancy, intrahepatic cholestasis,  
endothelium, infertility, ART. 
Intrahepatic cholestasis is characterized by the damage of endothelial cells of hepatic sinusoids, changes in the 
intrahepatic hemodynamics, increased production of cytokines and free radicals. The processes of angiogenesis in 
the liver are also closely connected with the functional capacity of endothelium. The L-arginine level in blood was 
measured using the photometric method based. The homocysteine level was measured by the enzymatic cycling 
method. To measure the level of placental growth factor (PGF) in blood plasma samples, we used the 
immunochemical method. 
The research has found especially severe complications in the course of pregnancy after ART in those women with 
intrahepatic cholestasis whose placentas developed under the conditions of endothelial dysfunction from the very 
beginning of pregnancy. 
So, these factors may be early prognostic markers of severe obstetrical and perinatal disorders in women with 
induced pregnancy and hepatobiliary disorders. 
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Introduction. Cholestatic hepatosis of pregnancy (or intrahepatic cholestasis of pregnancy - 
IHCP) is a cholestatic disease that manifests itself in the 2nd or the 3rd trimester of pregnancy in 
pruritus, increased levels of aminotransferases and bile acids (BA), changes in the activity of hepatic 
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enzymes and is characterized by spontaneous disappearance of signs and symptoms within two or 
three weeks after labor [1, 2]. In some studies, IHCP is also called idiopathic intrahepatic cholestasis 
or hepatosis of pregnancy. Indeed, it is a transitory hepatic dysfunction that disappears within 1 to 3 
weeks after labor. IHCP was first mentioned by F. Ahlfeld in 1883 in the Reports and Records of the 
Clinic of Obstetrics and Gynecology in Hessen [3].  
One should also bear in mind that, due to the exhaustion of its reserve potential in the course of 
pregnancy, the liver becomes more vulnerable (Sidorova І.S., 2003; Friedman S.A., 1998, Girling J., 
1997). One should pay special attention to its functioning in case of development of gestational 
toxicosis; in the pathogenesis of its severe forms, changes in the hepatobiliary system are the key factor 
(Christina Song, 1998).  
Intrahepatic cholestasis of pregnancy is observed in 1-2 out of 1000 pregnancies in the United 
States [4]. As a rule, it manifests itself in the 3rd trimester, with the onset around the 30th week of 
pregnancy (on average) and the disappearance of symptoms after labor. The differential diagnosis 
includes viral hepatitis, autoimmune hepatitis, primary biliary hepatic cirrhosis and cholelithiasis.  
Additional risk factors include the pregnant woman’s age, multifetal pregnancy, diseases in 
anamnesis or in relatives, liver diseases before the pregnancy, cholestasis, intake of oral contraceptives [5, 6]. 
There are several theories of the disease pathogenesis, including the hormonal, the genetic and 
other theories. According to the hormonal theory, increased secretion of progesterone and other 
placental hormones in the pregnant woman’s body impedes the release of gonadotropic hormones 
from the hypophysis and leads to increased cholesterol synthesis in the liver and decreased capacity of 
the membranes of hepatocytes and bile canaliculi to release bile acids. What lies at the basis of 
pathogenesis is a disorder of cholepoiesis and choleresis as 17β-estradiol gets to bile canaliculi and 
inhibits the bile salt export pump, hampering the transport of bile acids into bigger ducts [7,8]. 
Endothelial dysfunction is known to be a universal pathogenic mechanism of the majority of 
diseases as endothelium does not only regulate vascular tone but is also involved in the processes of 
atherogenesis, thrombosis and protection of the integrity of vessel walls [Golovchenko Y.I., 
Treshchinskaya M.A., 2008]. Besides, endothelium produces a big number of biologically active 
substances that influence vascular tone and angiogenesis, regulate hemostasis, adhesion and aggregation 
of platelets, immune and anti-inflammatory responses [Gomazkov О.А., 2000; Aird W.C., 205]. 
Liver diseases are characterized by the damage of endothelial cells of hepatic sinusoids, 
changes in the intrahepatic hemodynamics, increased production of cytokines and free radicals 
[Yermolov S.Y., 2000]. The processes of angiogenesis in the liver are also closely connected with the 
functional capacity of endothelium. Nitric oxide (NO) is synthesized by hepatocytes and cells of the 
reticulo-endothelial system of the liver [Ratnikova L.I., Melnikov I.V., 2002]. Affected by chronic 
processes, the liver suffers from the inhibition of the NO biosynthesis processes, which leads to an 
imbalance between vasoconstrictors and vasodilators [Hon W.M., 2002]. 
Aim of research – identifying the role of endothelial dysfunction and factors of vascular 
homeostasis regulation in the development of obstetrical and perinatal complications in women with 
infertility treated with ART and with concomitant intrahepatic cholestasis. 
Materials and methods of research. We have analyzed and divided into groups 90 women 
with infertility treated with ART. The basic group consisted of 50 women diagnosed with intrahepatic 
cholestasis in the 2nd and the 3rd trimester of pregnancy, while the other 40 women did not present the 
above mentioned disorder (comparison group). In addition and contrast to these 90 women with 
infertility treated with assisted reproductive technologies, we have also considered 20 women who got 
pregnant without ART (reference group). 
The L-arginine level in blood was measured using the photometric method based on the reaction of 
α-naphthol with a hypobromite reagent. The homocysteine level was measured by the enzymatic cycling 
method with the use of the DiaSys kit (Germany) and the Respons 920 analyzer (Germany), following the 
producer’s instructions. To measure the level of placental growth factor (PGF) in blood plasma samples, 
we used the immunochemical method with electrochemiluminescent immunoassay (ECLIA). 
Research results and their discussion. Endothelial dysfunction also plays an important role 
in reproductive disorders, in particular infertility and recurrent miscarriage [9, 10]. Some authors even 
consider it to be the basis of pathogenesis of such conditions. 
Among the numerous factors of endothelial origin, nitric oxide (NO) is a generally recognized 
marker of endothelial dysfunction. Nitric oxide is produced from L-arginine under the influence of the 
nitric oxide synthase enzyme (NOS). It is to this L-arginine / nitric oxide system that the contemporary 
obstetrics attributes the major vasoregulatory role in the gestational period [11, 12]. 
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Special importance for the development of the vascular network of placenta and for its normal 
functioning is attributed to the vascular factors that stimulate the proliferation of endothelial cells and 
increase their viability, which include the vascular endothelial growth factor (VEGF), the placental 
growth factor (PGF) and the basic fibroblast growth factor (bFGF) [13, 14]. 
An important factor of reproductive and obstetrical disorders is hyperhomocysteinemia, which 
leads to the damage and activation of endothelial cells and significantly increases the risk of thrombosis. 
Homocysteine induces apoptosis of trophoblastic cells and significantly decreases the production of 
chorionic gonadotropin, which may cause obstetric complications related to implantation disorders [15]. 
Taking into account the contemporary view of endothelial dysfunction as a universal trigger 
mechanism of reproductive disorders, the role of vascular changes in the placentation process disorder as 
well as the genetic susceptibility of women with infertility diagnosed with intrahepatic cholestasis to 
endothelial dysfunction (unfavorable variants of the еNOS gene polymorphism) that we found in our 
research, we considered it necessary to study in such women the levels of L-arginine as the NO donor, of 
homocysteine as an endothelium-damaging factor and of PGF as a factor of angiogenesis [16, 17, 18]. 
We have researched the indicators that characterize endothelial function and may damage 
endothelium in 50 women with infertility treated with ART and with concomitant intrahepatic 
cholestasis (basic group), in 40 women without such hepatobiliary disorders (comparison group) and 
in 20 women who got pregnant without ART (reference group). The research rуsults (Table 1) have 
shown in the women of the basic group a decreased level of L-arginine, that is the only source of nitric 
oxide – the main vasorelaxant factor (44.9±1.1 vs. 49.6±1.3, p<0.05), which may be indicative of 
endothelial dysfunction. We have also noticed a trend towards hyperhomocysteinemia, which implies 
a high risk of endothelium damage, negative influence on the coagulation system, microcirculation 
disorders and negative influence on the reproductive function. [19, 20, 21]. 
 
Table 1. Indicators of vascular hemostasis regulation in women with infertility and functional 
hepatic disorders 
Indicator 
Group of women 
Basic group Comparison group  Reference group 
L-arginine, mmol/l 44.9±1.1 49.6±1.3 53.6±1.4 
Homocysteine, micromole/l 6.5±0.36 5.7±0.32 6.2±0.32 
Note: * - the difference is significant with regard to the indicator in women from the comparison 
group (p<0.05). 
To assess the condition of vascular regulation in pregnant women with functional hepatic disorders 
after treatment with ART, depending on the development of obstetric and perinatal complications, we have 
studied the respective indicators in 50 women with intrahepatic cholestasis (basic group), 40 pregnant 
women treated with ART but presenting no hepatobiliary disorder (comparison group) and 20 healthy 
women who got pregnant naturally (reference group) in the 14-16th week of pregnancy. As shown in Table 
2, the women of the basic group present significant changes in the analyzed indicators. For instance, one 
can see a significant decrease in comparison with the reference group of the L-arginine level (44.2±1.1 vs. 
52.6±1.4 mmol/l (p<0.05)) and an increase of the homocysteine level. One should also note a significantly 
decreased level of PGF in blood (91.4±8.6 vs. 132.4±11.5 pg/ml in women from the reference group, 
p<0.05), which is indicative of disorders of the angiogenesis processes, which, in their turn, have a negative 
impact on the development and functioning of placenta and lead to complications of pregnancy and 
disorders of the condition of the fetus, which were often observed in women with hepatobiliary changes. 
 
Table 2. Indicators of vascular homeostasis regulation in pregnant women after ART 
Indicator Group of pregnant women 
Basic group Comparison group  Reference group 
L-arginine, mmol/l (44.2±1.1)* 47.3±1.3 52.6±1.4 
Homocysteine, micromole/l (6.9±0.30)* 6.2±0.36 5.8±0.33 
PGF in blood, pg/ml (91.4±8.6)* 118.8±9.5 132.4±11.5 
Note: * - the difference is significant with regard to the indicator in women from the reference group (p<0.05). 
To identify the role of the disorders of vascular homeostasis regulation in the development of 
complications of pregnancy in case of hepatic disorders, we have singled out 2 subgroups in the basic group: 
Subgroup 1 – 19 women with significant obstetrical and perinatal disorders (miscarriages and non-
developing pregnancies, severe preeclampsia, decompensated fetal distress), Subgroup 2 – 31 women 
without such disorders. The research results show (Table 4) especially severe complications in the course of 
pregnancy after ART in those women with intrahepatic cholestasis whose placentas developed from the very 
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beginning of pregnancy under the conditions of endothelial dysfunction (decrease of the L-arginine level to 
39.8±2.0 mmol/ l vs. 45.8±1.6 in women without significant disorders of the gestational process, p<0.05), 
negative influence of homocysteine (increase to 7.4±0.44 vs. 6.4±0.36 micromole/l, p<0.05), disorders of 
angiogenesis processes (decrease of the PGF level in blood to 70.5±11.9 vs. 103.7±9.8 pg/ml, p<0.05).  
 
Table 3. Indicators of vascular homeostasis regulation in pregnant women after ART 
Indicator Subgroup of women 
1  2 
L-arginine, mmol/l (39.8±2.0)*  45.8±1.6 
Homocysteine, micromole/l (7.4±0.44)*  6.4±0.36 
PGF in blood, pg/ml (70.5±11.9)* 103.7±9.8 
Note: * - the difference is significant with regard to the indicator in women of Subgroup 2 (p<0.05).  
 
So, these factors may be early prognostic markers of such obstetrical and perinatal disorders in 
case of induced pregnancy. 
Conclusions. Especially severe complications in the course of pregnancy after ART were 
observed in those women with intrahepatic cholestasis whose placentas developed from the very 
beginning of pregnancy under the conditions of endothelial dysfunction (decreased L-arginine level), 
negative influence of homocysteine and disorders of angiogenesis processes (decreased PGF level in 
blood). Thus, these factors may be early prognostic markers of severe obstetrical and perinatal 
disorders in case of induced pregnancy. 
Conflict of Interest. The authors confirm that there are no conflicts of interest. 
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